We are a multinational pharmaceutical group dedicated to improving the health and wellbeing of people in the markets we serve through the development, manufacture and marketing of a broad range of solid, liquid and injectable generic and in-licensed pharmaceutical products.
- 17-Mar-2009
- » Preliminary results announcement for the year ended 31 December 2008
- LONDON, 17 March 2009 - Hikma Pharmaceuticals PLC (”Hikma”) (LSE:HIK) (DIFX:HIK), the fast-growing multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of generic and in-licensed pharmaceutical products, across the Middle East and North Africa, the US and Europe, today reports its preliminary results for the year ended 31 December 2008. Download full preliminary results announcement
- 17-Mar-2009
- » Interview with Mr Said Darwazah regarding 2008 Preliminary results
- Interview with Mr Said Darwazah on Hikma’s 2008 Preliminary results.
